Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs LMAT

ACADIA Pharmaceuticals Inc. vs LeMaitre Vascular, Inc. — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
69
Buy
VS
LMAT
LeMaitre Vascular, Inc.
57
Watch
MetricACADLMAT
AI Score 69 57
Price $29.41 $82.83
P/E Ratio 13.07× 28.57×
ROE 31.9% 14.7%
Revenue Growth YoY
Gross Margin 91.1% 72.9%
Debt / Equity 0.06× 0.45×
Dividend Yield 0.0% 1.1%
RSI (14) 78.4 31.2
Beta 0.845 0.524
Expected Upside

AI Committee View

Current Innellis committee reasoning for ACAD versus LMAT.
ACAD leads by 12 points.

ACAD scores 69/100 (Buy) versus LMAT at 57/100 (Watch).

ACAD Committee View
83% agreement
6 analysts

The primary driver is revenue growing 47.0% yoy -- genuine top-line momentum. The main limiting factor is bollinger bandwidth of 24.3% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 13.2 is inexpensive for the broad market — Value
  • ROE of 32.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 47.0% YoY -- genuine top-line momentum — Growth
Bear Case
  • RSI at 78 is in overbought territory — Technical
  • Weekly RSI at 80 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 24.3% signals elevated volatility — Risk
LMAT Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 38.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 16.4% shows genuine earnings power backing the valuation — Value
  • EPS growing 34.4% YoY — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • P/E of 28.6 is moderate-to-rich — Value
  • Price-to-book of 4.7x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis LMAT Full Analysis